Analytical Data
-
基因名
FGFR-4
- Application
-
别名
CD334; JTK2; TKF
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P22455
-
表达区间
Val168~Asp369
-
分子量
27kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Fibroblast growth factor receptor 4 (FGFR-4) is a pivotal member of the fibroblast growth factor receptor family, involved in various physiological processes, including cell proliferation, differentiation, and survival. Research has demonstrated that FGFR-4 plays a critical role in several pathological conditions, including cancer, where its aberrant expression is linked to tumor progression and metastatic potential. Understanding the structural and functional dynamics of FGFR-4 has become essential for developing targeted therapies against cancers associated with its dysregulation. Recombinant FGFR-4 proteins are utilized in studies to elucidate the receptor's signaling mechanisms, interactions with ligands, and downstream effectors. These proteins can also aid in high-throughput screening for novel inhibitors that may serve as potential therapeutic agents. Moreover, FGFR-4 is implicated in muscle development and repair, highlighting its importance beyond oncology. By producing and characterizing FGFR-4 recombinant proteins, researchers aim to gain insights into its biological roles and therapeutic targeting, paving the way for innovative treatment strategies for diseases linked to FGFR-4 dysregulation.
